DeepMind unveils AlphaGenome 2 for cell-level DNA predictions
First merged summary.
Google DeepMind released AlphaGenome 2, which predicts how DNA variants affect cells, via a non-commercial API.
Google DeepMind unveiled AlphaGenome 2 on November 11, 2026, a conditional successor to AlphaGenome that predicts how a DNA sequence and its variants affect one tissue, cell type, or cell state. The company says it was trained on more than 100 million single-cell profiles across 68 tissues, finds nearly twice as many expression-changing variants as the prior model, and can predict unseen cell types without retraining. Outputs now include DNA methylation; inputs remain one-million-letter sequences paired with a biological condition. Non-commercial research is open through the AlphaGenome API, while commercial research is in a limited private preview. The original AlphaGenome remains for cheaper genome-wide predictions, and DeepMind says finer predictions cost more to compute.
- Trained on more than 100 million profiles across 68 tissues.
- Nearly twice as many expression-changing variants as the prior model.
- TenK10K immune-cell causal-variant recall reported at 30% versus 16%.
- Non-commercial API access; commercial research in private preview.
- Original AlphaGenome still handles cheaper genome-wide predictions.
- DeepMind plans more data and possible multi-species training.
Timeline
dated events in the reporting · oldest first- Nov 11, 2026DeepMind unveils AlphaGenome 2 and opens research API · Google DeepMind
What each outlet adds
beyond the shared facts- The VergeOriginal model stays; unseen cell types and multi-species plans.
- Google DeepMindAdds methylation, TenK10K recall, and cell-encoder conditioning.
- Vendors
- GoogleGoogle DeepMind
- Products
- AlphaGenome API
- Organizations
- Google DeepMind
- AI models
- AlphaGenome 2AlphaGenome
Coverage
oldest first · one row per article · UTCDeepMind unveils AlphaGenome 2 for cell-level genetic variant effects
Trained on more than 100 million cell profiles, it is available today for non-commercial research through the AlphaGenome API.
DeepMind announces AlphaGenome 2 for cell-type DNA predictions
The conditional model, trained on over 100 million cell profiles, is available for non-commercial use via an API.